SCR7 pyrazine, NHEJ inhibitor (ab222375)
Key features and details
- Small molecule NHEJ inhibitor
- CAS Number: 14892-97-8
- Purity: > 98%
- Soluble in DMSO to 100 mM and in ethanol to 20 mM
- Form / State: Solid
- Source: Synthetic
Overview
-
Product name
SCR7 pyrazine, NHEJ inhibitor -
Description
Small molecule NHEJ inhibitor -
Biological description
Small molecule nonhomologous end-joining (NHEJ) inhibitor. SCR7 analog. Enhances CRISPR-Cas9-mediated homology-directed repair (HDR) efficiency in vitro.
-
Purity
> 98% -
General notes
This product is manufactured by BioVision, an Abcam company and was previously called B1119 SCR7 pyrazine. B1119-25 is the same size as the 25 mg size of ab222375.
-
CAS Number
14892-97-8
Properties
-
Chemical name
2,3-Dihydro-6,7-diphenyl-2-thioxo-4(1H)-pteridinone -
Molecular weight
332.38 -
Molecular formula
C18H12N4OS -
PubChem identifier
10688007 -
Storage instructions
Shipped at 4°C. Store at -20°C long term. Store In the Dark. Store under desiccating conditions. -
Solubility overview
Soluble in DMSO to 100 mM and in ethanol to 20 mM -
Handling
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Refer to SDS for further information.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
-
SMILES
C1=CC=C(C=C1)C2=NC3=C(NC(=S)NC3=O)N=C2C4=CC=CC=C4 -
Source
Synthetic
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (0)
ab222375 has not yet been referenced specifically in any publications.